Skip to main content
CHEIL BIO CO., LTD. logo

CHEIL BIO CO., LTD. — Investor Relations & Filings

Ticker · 052670 ISIN · KR7052670007 KO Manufacturing
Open in API
Filings indexed 291 across all filing types
Latest filing 2025-08-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 052670

About CHEIL BIO CO., LTD.

http://www.cheilbio.com/en/index.php

CHEIL BIO CO., LTD. is a company that develops, manufactures, and markets a wide range of advanced veterinary products. The company focuses on improving the health and productivity of livestock through solutions based on extensive research and biotechnology. Its core offerings include animal medicines, such as antibiotics and antimicrobials, and functional feed additives. These products cater to a diverse market, including the swine, poultry, cattle, and aquaculture sectors, as well as companion animals. The company leverages its dedicated research and development capabilities to create high-quality, market-competitive products and aims to achieve global technological competitiveness in the animal health industry.

Recent filings

Filing Released Lang Actions
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company '제일바이오' (Cheilbio Co., Ltd.) covering the period from January 1, 2025, to June 30, 2025. It contains detailed financial information, business descriptions, and management disclosures required for a semi-annual filing in Korea. According to the provided definitions, a comprehensive financial report for a period shorter than a full fiscal year (like a half-year report) is classified as an Interim / Quarterly Report (IR). H1 2025
2025-08-14 Korean
반기검토(감사)의견부적정등사실확인(자본잠식률100분의50이상또는자기자본10억원미만포함)
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding 'Audit Opinion Disclaimer' (adverse/disclaimer of opinion) and capital impairment status for Jeil Bio. It explicitly details the auditor's inability to obtain sufficient evidence and the resulting 'disclaimer of opinion' (의견거절). While it references a semi-annual report, the document itself is a specific regulatory disclosure regarding the audit outcome and financial status, which falls under the category of Audit Report/Information (AR) as it pertains to the results of the audit process. H1 2025
2025-08-14 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of an Extraordinary General Meeting (EGM) for the company '제일바이오' (Jeil Bio). It details the voting outcomes for specific agenda items, including amendments to the articles of incorporation, stock conversion, and capital reduction. Since it reports the official results of shareholder votes at a general meeting, it falls under the 'Declaration of Voting Results & Voting Rights Announcements' category.
2025-08-01 Korean
[기재정정]액면주식ㆍ무액면주식전환결정
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding a 'Decision to convert par value shares to no-par value shares'. This involves a change in the company's capital structure and share characteristics. Since it does not fit into specific categories like dividend announcements, director dealings, or M&A, and is a formal regulatory disclosure regarding corporate structure, it falls under the 'Regulatory Filings' (RNS) category as the most appropriate fallback for miscellaneous corporate announcements.
2025-08-01 Korean
[기재정정]주요사항보고서(감자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a capital reduction (감자 결정) and stock consolidation (주식병합) for CheilBio. It details the specific procedures, legal basis (Commercial Code), and updated timelines for the capital reduction process. This type of corporate action announcement, which involves changes to share capital and structure, falls under the 'Share Issue/Capital Change' category as it directly relates to the company's capital structure and share count.
2025-08-01 Korean
횡령ㆍ배임혐의진행사항
Legal Proceedings Report Classification · 100% confidence The document is a regulatory disclosure regarding the status of legal proceedings (embezzlement and breach of trust) involving a former executive of the company. It provides updates on a specific legal case, including the status of an appeal. Since it pertains to significant legal matters and regulatory disclosures regarding corporate misconduct, it falls under the 'Legal Proceedings Report' category.
2025-07-21 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.